We
compared different biofunctionalization strategies
for immobilizing
trastuzumab, an IgG targeting the HER2 biomarker, onto 100 nm spherical
gold nanoparticles because of the E/K coiled-coil peptide heterodimer.
First, Kcoil peptides were grafted onto the gold surface while their
Ecoil partners were genetically encoded at the C-terminus of trastuzumab’s
Fc region, allowing for a strong and specific interaction between
the antibodies and the nanoparticles. Gold nanoparticles with no Kcoil
peptides on their surface were also produced to immobilize Ecoil-tagged
trastuzumab antibodies via the specific adsorption of their negatively
charged Ecoil tags on the positively charged gold surface. Finally,
the nonspecific adsorption of wild-type trastuzumab on the gold surface
was also assessed, with and without Kcoil peptides grafted on it beforehand.
We developed a thorough workflow to systematically compare the immobilization
strategies regarding the stability of nanoparticles, antibody coverage,
and ability to specifically bind to HER2-positive breast cancer cells.
All nanoparticles were highly monodisperse and retained their localized
surface plasmon resonance properties after biofunctionalization. A
significant increase in the amount of immobilized antibodies was observed
with the two oriented coil-based strategies compared to nonspecific
adsorption. Finally, all biofunctionalization strategies allowed for
the detection of HER2-positive breast cancer cells, but among the
investigated approaches, we recommend using the E/K coiled-coil-based
strategy for gold nanoparticle biofunctionalization because it allows
for the qualitative and quantitative detection of HER2-positive cells
with a higher contrast compared to HER2-negative cells.